The gut microbiome plays a crucial role in regulating host health, with its complex interactions with the host being increasingly understood through molecular techniques. Deviations in the gut microbiome are linked to various diseases, including obesity, type 2 diabetes, hepatic steatosis, intestinal diseases, and cancer. This review critically evaluates current understanding of the mechanisms by which gut bacteria influence health. It discusses well-established metabolites like short-chain fatty acids (SCFAs), bile acids, and trimethylamine N-oxide, as well as newly identified molecular actors such as endocannabinoids, bioactive lipids, and enterosynes, and their specific receptors. Understanding these molecular interactions is essential for developing novel therapies. The human gut microbiome consists of microbes, their genes, and their products that colonize the body since birth. The gut contains the highest microbial numbers, with the small intestine showing a concentration gradient of microbes. The colon hosts a diverse community of anaerobic bacteria, including thousands of species and millions of genes. The gut microbiome is highly modifiable by diet and drugs and is associated with various diseases. Faecal microbiota transplantation (FMT) has shown promise in treating recurrent Clostridioides difficile infections and other diseases. The gut microbiome is involved in various intestinal and extraintestinal disorders, including inflammatory bowel diseases (IBDs), coeliac disease, irritable bowel syndrome (IBS), colorectal cancer (CRC), and chronic liver diseases. The microbiome influences these conditions through its impact on immune function, energy metabolism, and inflammation. The gut microbiome also plays a key role in metabolic disorders such as obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD). The gut microbiome-liver axis is particularly important in NAFLD, with microbial changes affecting liver function. The gut microbiome produces various metabolites that influence host health, including SCFAs, bile acids, and lipopolysaccharides (LPS). SCFAs, such as butyrate, play a critical role in maintaining gut barrier function and regulating energy metabolism. The gut microbiome also interacts with the endocannabinoid system, which is involved in energy homeostasis, glucose regulation, and inflammation. The aryl hydrocarbon receptor (AhR) is another key player in gut microbiome-host interactions, influencing energy metabolism, inflammation, and immune function. The gut microbiome is also involved in the metabolism of bile acids, which are crucial for lipid digestion and absorption. Bile acids can be modified by gut microbes, leading to the formation of secondary bile acids that influence metabolic responses. The gut microbiome also produces various signaling molecules, including enterosynes, which can modulate gut function by targeting the enteric nervous system. In conclusion, the gut microbiome plays a complex and multifaceted role in host health, influencing various physiological processes and disease states. Understanding the molecular mechanisms linking the gutThe gut microbiome plays a crucial role in regulating host health, with its complex interactions with the host being increasingly understood through molecular techniques. Deviations in the gut microbiome are linked to various diseases, including obesity, type 2 diabetes, hepatic steatosis, intestinal diseases, and cancer. This review critically evaluates current understanding of the mechanisms by which gut bacteria influence health. It discusses well-established metabolites like short-chain fatty acids (SCFAs), bile acids, and trimethylamine N-oxide, as well as newly identified molecular actors such as endocannabinoids, bioactive lipids, and enterosynes, and their specific receptors. Understanding these molecular interactions is essential for developing novel therapies. The human gut microbiome consists of microbes, their genes, and their products that colonize the body since birth. The gut contains the highest microbial numbers, with the small intestine showing a concentration gradient of microbes. The colon hosts a diverse community of anaerobic bacteria, including thousands of species and millions of genes. The gut microbiome is highly modifiable by diet and drugs and is associated with various diseases. Faecal microbiota transplantation (FMT) has shown promise in treating recurrent Clostridioides difficile infections and other diseases. The gut microbiome is involved in various intestinal and extraintestinal disorders, including inflammatory bowel diseases (IBDs), coeliac disease, irritable bowel syndrome (IBS), colorectal cancer (CRC), and chronic liver diseases. The microbiome influences these conditions through its impact on immune function, energy metabolism, and inflammation. The gut microbiome also plays a key role in metabolic disorders such as obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD). The gut microbiome-liver axis is particularly important in NAFLD, with microbial changes affecting liver function. The gut microbiome produces various metabolites that influence host health, including SCFAs, bile acids, and lipopolysaccharides (LPS). SCFAs, such as butyrate, play a critical role in maintaining gut barrier function and regulating energy metabolism. The gut microbiome also interacts with the endocannabinoid system, which is involved in energy homeostasis, glucose regulation, and inflammation. The aryl hydrocarbon receptor (AhR) is another key player in gut microbiome-host interactions, influencing energy metabolism, inflammation, and immune function. The gut microbiome is also involved in the metabolism of bile acids, which are crucial for lipid digestion and absorption. Bile acids can be modified by gut microbes, leading to the formation of secondary bile acids that influence metabolic responses. The gut microbiome also produces various signaling molecules, including enterosynes, which can modulate gut function by targeting the enteric nervous system. In conclusion, the gut microbiome plays a complex and multifaceted role in host health, influencing various physiological processes and disease states. Understanding the molecular mechanisms linking the gut